ALLAY-HF: Safety and Efficacy of the Alleviant System for No-Implant Interatrial Shunt Creation in Patients with Chronic Heart Failure06/13/2023 - 06/13/2028 (PI)
Alleviant Medical, Inc.
Cardiopulmonary Exercise MRI in Heart Failure with Preserved Ejection Fraction09/01/2021 - 08/31/2026 (PI)
Beth Israel Deaconess Medical Center National Heart, Lung1R01HL158077-01
CLCZ696DUS01: “A multicenter, randomized, double-blind, doubledummy, parallel group, active controlled 8-week study to evaluate the effect of sacubitril/valsartan (LCZ696) versus valsartan on changes in NT-proBNP and safety and tolerability of in-hospital05/31/2022 - 05/31/2025 (PI)
Novartis Pharma Corp
CARS Registry09/01/2021 - 08/31/2023 (PI)
Cedars-Sinai Medical Center
Cardiac Phenotyping to Identify Preclinical Heart Failure in Metabolic Syndrome07/01/2017 - 06/30/2023 (PI)
American Heart Association/AHA
Study to evaluate the efficacy and safety of LCZ69609/15/2014 - 08/31/2021 (PI)
Novartis Pharma Corp